Viewing Study NCT05086692


Ignite Creation Date: 2025-12-24 @ 3:07 PM
Ignite Modification Date: 2026-02-21 @ 1:39 PM
Study NCT ID: NCT05086692
Status: RECRUITING
Last Update Posted: 2025-07-09
First Post: 2021-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Beta-only IL-2 ImmunoTherapY Study
Sponsor: Medicenna Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module